Loma Therapeutics was awarded for Merck’s Advance Biotech Grant for their pitch at the Nordic Stars Pitch Competition.
CEO Ditte Boilesen and COO Stephanie Holstein-Rønsbo received the award on stage, which includes bioprocessing technologies and services valued at 45,000 EUR. Loma Therapeutics showcased its innovative HPV-specific immunotherapy, which promises to revolutionize the treatment landscape for HPV-related cancers.
The recognition at NLSDays underscores Loma Therapeutics’ commitment to addressing unmet medical needs and driving advancements in the life sciences industry. As the company continues to make strides in its entrepreneurial journey, its dedication to innovation and excellence serves as a beacon of hope for individuals affected by HPV disease worldwide.
Read more at: https://nordiclifescience.org/three-winners-announced-during-nlsdays/